Skip to main content

Table 1 Baseline characteristic of studies included in the systematic review and meta-analysis

From: Folate intake, serum folate levels, and prostate cancer risk: a meta-analysis of prospective studies

Study

Country

Study design

Assessment of exposure

Sample size

Age at baseline

Effect estimate

Comparison categories

Follow-up (year)

Covariates in fully adjusted model

SJ Weinstein8 2006

Finland

Cohort

FFQ

27111

50-69

RR

>378 μg/d versus <283 μg/d

12.4

Age, vitamin supplement use, energy intake

VL Stevens9 2006

US

Cohort

FFQ

65836

50-74

RR

>347 μg/d versus <204 μg/d

9.0

Age, race, education, total calories, total calcium, ethanol, family history of prostate cancer, vitamin B12, prostate-specific antigen screening, and history of diabetes

JK Bassett10 2012

Australia

Cohort

FFQ

14620

40-69

HR

444 μg/d versus 215 μg/d

15.0

Country of birth, education, alcohol consumption, BMI, and daily intakes of lycopene and calcium

BAJ Verhage11 2012

Netherland

Cohort

FFQ

58279

55-69

HR

>259.1 μg/d versus <176.5 μg/d

17.3

Age

N Roswall12 2013

Denmark

Cohort

Self-administer questionnaire

26856

50-64

HR

>412.9 μg/d versus <280.5 μg/d

17.0

Intake of the three other micronutrients as well as dietary intake for the supplemental intake and supplemental intake for the dietary intake and further for height, weight, education, intake of red meat, alcohol consumption, selenium intake

M Johansson13 2008

Europe

Nest case control

Blood samples

2043

58.7

RR

>16.55 nmol/L versus <4.82 nmol/L

5.0

Body mass index, smoking status, alcohol intake, physical activity, marital status, and education level

J Beilby14 2010

Australia

Nest case control

Blood samples

321

69.5

OR

Tertiles 3 versus tertiles 1

6.0

Age, administered vitamin A supplement

S Vogel15 2013

Norway

Nest case control

Blood samples

6000

49.1

OR

>17.5 nmol/L versus <10.9 nmol/L

15.7

Serum creatinine concentration, education, smoking, physical activity and body mass index.

J Hultdin7 2005

Sweden

Nest case control

Blood samples

768

58.2

OR

>10.3 nmol/L versus <5.85 nmol/L

4.9

Other 2 plasma variables, BMI and smoking

SJ Weinstein16 2003

Finland

Nest case control

Blood samples

678

50-69

OR

>10.79 nmol/L versus <6.87 nmol/L

6-9

Benign prostate hyperplasia